Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | ALIM | RNAC | ||
| Company | Adaptimmune Ther ADR | Alimera Sciences Inc | Cartesian Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.2000 | 5.56 | 16.25 | ||
| High | 1.2700 | 5.58 | 17.25 | ||
| Low | 1.1650 | 5.56 | 15.68 | ||
| Last | 1.2100 | 5.58 | 16.85 | ||
| Change | +0.0400 | +0.01 | +0.69 | ||
| % Change | +3.42% | +0.18% | +4.27% | ||
| Volume | 1,209,000 | 84,400 | 128,700 | ||
| 20-Day Average Volume | 1,708,120 | 809,275 | 275,560 | ||
| Previous Close | 1.1700 | 5.57 | 16.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.1139 | 5.55 | 19.60 | ||
| 20-Day Raw Stochastic | 70.64% | 50.00% | 10.74% | ||
| 20-Day Relative Strength | 55.97% | 75.82% | 39.72% | ||
| Weighted Alpha | -12.07 | +15.44 | -49.53 | ||
| Today's Opinion | 56% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 40% Buy | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 40% Sell | 88% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.81% since 07/15/24 | +0.36% since 07/15/24 | -5.97% since 07/15/24 | ||
| Low | 1.1300 on 07/19/24 | 5.56 on 07/22/24 | 15.68 on 07/22/24 | ||
| High | 1.3100 on 07/17/24 | 5.60 on 07/16/24 | 20.99 on 07/18/24 | ||
| 1-Month | |||||
| %Chg | +35.96% since 06/21/24 | +77.14% since 06/21/24 | -26.10% since 06/21/24 | ||
| Low | 0.8250 on 06/26/24 | 5.51 on 06/26/24 | 15.31 on 07/05/24 | ||
| High | 1.3700 on 07/15/24 | 5.65 on 06/24/24 | 29.65 on 06/27/24 | ||
| 3-Month | |||||
| %Chg | +19.80% since 04/22/24 | +57.63% since 04/22/24 | -7.72% since 04/22/24 | ||
| Low | 0.8250 on 06/26/24 | 2.77 on 06/10/24 | 15.31 on 07/05/24 | ||
| High | 1.3700 on 07/15/24 | 5.65 on 06/24/24 | 41.87 on 06/06/24 | ||
| 6-Month | |||||
| %Chg | +66.60% since 01/22/24 | +42.71% since 01/22/24 | -24.87% since 01/22/24 | ||
| Low | 0.6905 on 01/25/24 | 2.77 on 06/10/24 | 11.66 on 04/08/24 | ||
| High | 2.0500 on 03/08/24 | 5.65 on 06/24/24 | 41.87 on 06/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 288,785 | 291,807 | 287,583 | ||
| Shares Outstanding, K | 246,825 | 52,389 | 17,796 | ||
| Annual Sales | 60,280,000 | 80,750,000 | 26,000,000 | ||
| Annual Net Income | -113,870,000 | -20,130,000 | -219,710,000 | ||
| Last Quarter Sales | 5,680,000 | 23,010,000 | 5,840,000 | ||
| Last Quarter Net Income | -48,500,000 | -6,250,000 | -56,820,000 | ||
| 60-Month Beta | 2.31 | 1.28 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 05/15/24 | -0.12 on 05/14/24 | -1.97 on 05/08/24 | ||
| Latest Earnings Date | 08/14/24 | 08/08/24 | 08/15/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||